ShangPharma
Asia, Shanghai, China, Shanghai'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
Description
ShangPharma is a leading China-based outsourcing partner in pharmaceutical and biotechnology research and development, who provides
Investor Profile
ShangPharma has backed more than 5 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series B rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Biotechnology, Health Care, Therapeutics.
Stage Focus
- Series A (60%)
- Series B (40%)
Country Focus
- United States (100%)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Medical
- Clinical Trials
- Pharmaceutical
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
